Ling Qiu

机构：Sichuan Mianyang 404 Hospital · ORCID：0000-0002-2564-2240

发表论文 12 篇 · 总被引 119 次 · h-index 3

代表论文

• Serine Protease Inhibition and Mitochondrial Dysfunction Associated with Cisplatin Resistance in Human Tumour Cell Lines: Targets for Therapy (1997 · 被引 41)
• Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma (2020 · Bioscience Reports · 被引 37)
• MUC1 induces the accumulation of Foxp3+ Treg cells in the tumor microenvironment to promote the growth and metastasis of cholangiocarcinoma through the EGFR/PI3K/Akt signaling pathway (2023 · International Immunopharmacology · 被引 35)
• Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of CHOP plus auto-HSCT (2023 · Medicine · 被引 3)
• Study on the Preservation Effect of Radiation Technology on Fresh Day Lily (2008 · Journal of University of South China · 被引 2)
• CT-guided interstitial brachytherapy for locally advanced cervical cancer: introduction of the technique and report of dosimetry (2017 · Zhonghua fangshe zhongliuxue zazhi · 被引 1)